Question

A 63-year-old woman with new RA (DAS28 high) is seen in clinic. First-line disease-modifying strategy?

Accepted Answer

Methotrexate plus short-term bridging steroids

Answer

NSAIDs alone

Answer

Hydroxychloroquine monotherapy for all

Answer

Biologic immediately in primary care

Answer

Long-term oral steroids alone

Practice question

A 63-year-old woman with new RA (DAS28 high) is seen in clinic. First-line disease-modifying strategy?